Astrid A.M. van der Veldt

Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma

Maartje W. Rohaan, Troels Holz Borch, Joost H. van den Berg et al. · New England Journal of Medicine · 2022 · 474 citations · Full text

Rapid Decrease in Delivery of Chemotherapy to Tumors after Anti-VEGF Therapy: Implications for Scheduling of Anti-Angiogenic Drugs

Astrid A.M. van der Veldt, Mark Lubberink, Idris Bahce et al. · Cancer Cell · 2012 · 333 citations · Full text

Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the PRADO trial

Irene L. M. Reijers, Alexander M. Menzies, Alexander C. J. van Akkooi et al. · Nature Medicine · 2022 · 322 citations · Full text

Surgical Oncology, Oncology, Prado Trial +10

Impact of the coronavirus disease 2019 pandemic on cancer treatment: the patients’ perspective

Karlijn de Joode, Daphne W. Dumoulin, Vivian Engelen et al. · European Journal of Cancer · 2020 · 179 citations · Full text

Coronavirus Disease 2019, Virus Epidemiology, Covid-19 Pandemic +5

Sunitinib for Treatment of Advanced Renal Cell Cancer: Primary Tumor Response

Astrid A.M. van der Veldt, Martijn R. Meijerink, Alfons J.M. van den Eertwegh et al. · Clinical Cancer Research · 2008 · 170 citations